Experienced Leadership

Our Board of Directors is comprised of multicultural, experienced and diverse professionals who come from a wide variety of backgrounds. With this breadth of diversity, the Board can provide experiential oversight that is very relevant to the different end-markets and geographic regions in which we operate. We also believe in fresh perspectives and 50% of our Board has been renewed in the past five years.

Board Governance Highlights

  • 9 of 10 directors are independent
  • Separate independent Chairman & CEO
  • 30% of the Board is comprised of directors added in the past 2 years (50% in the past 5 years) as of the end of 2019
  • 40% of our directors are women; all Board Committees are chaired by women directors
  • Majority voting for directors and director resignation policy in uncontested elections
  • Director age limits
  • Independent directors meet regularly in executive session
  • Annual Board and Committee self-evaluations
  • Annual ‘‘Say-on-Pay Vote’’ on executive compensation
  • Stock ownership requirements for directors and executive officers
  • Prohibits directors and executive officers from hedging or pledging stock

Board of Directors

George L. Fotiades, Chairman of the Board


President and Chief Executive Officer of Cantel Medical Corp.; Director of Cantel Medical Corp. and Prologis, Inc.

Director since 2011

Giovanna Kampouri Monnas


Chairman of Exea International Company; Director of Puig S.L.

Director since 2010

Andreas Kramvis


Operating Partner, AEA Investors LP; Director, Axalta Coating Systems Ltd.

Director since 2014

Isabel Marey-Semper


Former Executive Vice President, Communications and Public Affairs, and General Manager for L'Oréal. Director of Damae Medical, Imagine Institute and Inria Foundation.

Director since 2019

Maritza Montiel


Former Deputy Chief Executive Officer (retired), Deloitte LLP; Director of McCormick & Company, Inc., Royal Caribbean Cruises Ltd. and Comcast Corporation.

Director since 2015

B. Craig Owens


Former Chief Financial Officer and Administrative Officer, Campbell Soup Company (retired); Director of JCPenney Company, Inc. and Dean Foods Company

Director since 2018

Dr. Joanne Smith


Physician and Chief Executive Officer of the Shirley Ryan Ability Lab; Director of Performance Health, Inc.

Director since 1999

Stephan B. Tanda


President and Chief Executive Officer of Aptar, Inc.

Independent Director of Ingredion

Director since 2017

Jesse Wu


Advisor to private equity firms; Former Chairman of Johnson & Johnson China and former Worldwide Chairman of the Johnson & Johnson Consumer Healthcare Division; Director of The a2 Milk Company Limited, Shanghai Kehua Bio - Engineering Co. Ltd. and Li

Director since 2018

Ralf K. Wunderlich


Senior advisor to private equity firms and independent consultant; Operating Partner for Bregal Unternehmerkapital; Director of Essentra PLC and Huhtamaki Oyj;

Director Since 2009

Committee Composition